Single company EIS

Single company EIS deals are private offers for experienced investors. 

They give you an opportunity to invest directly in a particular company you consider commercially compelling and able to deliver attractive returns, with the benefit of EIS tax relief. Please remember, tax rules can change and benefits depend on circumstances.

So, unlike with EIS funds where the asset manager makes the investment decisions on your behalf, you are in control, you decide which company to back. Get it right, and the reward could be considerable. 

But one cannot expect to get it right each time. You are investing in early-stage companies – inevitably some will fail. To help mitigate this, it might be wise to diversify and spread your EIS investments each year over a number of single companies.

How could you access single company deals? 

Thousands of EIS-qualifying companies raise funds. The latest figures show 4,215 businesses raised over £1.9 billion under EIS in just one year (2019/20). 

We aim to offer a selection of quality EIS opportunities you often wouldn’t be able to get elsewhere. Each has been carefully assessed, either by Wealth Club or by reputable and established counterparties. To help you make your own informed decisions, we provide you with insight and comment on each offer. This is free to Wealth Club members. 

  • Our choice

    Anaphite EIS

    Invest in high-potential cleantech company. Anaphite is developing potentially ground-breaking graphene technology to be used in electric car batteries. The technology aims to improve battery charging speeds, reduce manufacturing emission and lower production costs, and should be easy to integrate into current manufacturing processes.

    Read more about Anaphite EIS
    Type
    Single company
    Sector
    Technology
    Target return
    12.8x (IRR 67%)
    Funds raised / sought
    £1.5 million sought
    Minimum investment
    £20,069
    Deadline
    17 Jun for final close
  • Our choice

    Intelligent Lilli EIS

    Co-invest with West Hill Capital investors: digital health platform providing proactive remote monitoring for care sector. Lilli detects changes in the user's routine via in-home sensors and alerts carers. This enables intervention when required, but reduces the cost of care and allows patients to remain in their homes for longer.

    Read more about Intelligent Lilli EIS
    Type
    Single company
    Sector
    Technology
    Target return
    10.3x (59% IRR)
    Funds raised / sought
    £6.0 million sought
    Minimum investment
    £25,000
    Deadline
    27 May 2022 for first allotment
  • Our choice

    Salus Optima EIS

    Fast-growing personalised wellness platform backed with multi-year blue-chip contracts. In partnership with Formula 1™ team, McLaren Racing, Salus Optima has developed a data-driven platform that turns user inputs (real-time activity data or health questionnaire answers) into bespoke recommendations and coaching for managing and improving health and wellbeing – via the user’s smartphone or wearable device.

    Read more about Salus Optima EIS
    Type
    Single company
    Sector
    Healthcare & Technology
    Target return
    8.3x (53% IRR)
    Funds raised / sought
    £2.5 million / £3.0 million
    Minimum investment
    £19,775
    Deadline
    27 May 2022 for 2022/23 allotment
  • Our choice

    SolasCure EIS

    Co-invest alongside Abcam’s Jonathan Milner, VCs and global biopharmaceuticals in biotech company developing patented chronic wound treatment. SolasCare is developing a topical hydrogel – Aurase® – which should lead to faster wound cleaning, better patient outcomes and reduced healthcare costs.

    Read more about SolasCure EIS
    Type
    Single company
    Sector
    Healthcare
    Target return
    13.6x (IRR 45%)
    Funds raised / sought
    £4.4 million / £5.0 million
    Minimum investment
    £20,000
    Deadline
    31 May for next allotment